{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T07:46:23Z","timestamp":1776152783261,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["243785Pj01H"],"award-info":[{"award-number":["243785Pj01H"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015230","name":"Fondation Cancer","doi-asserted-by":"publisher","award":["FBKS-2024\\u20137-583"],"award-info":[{"award-number":["FBKS-2024\\u20137-583"]}],"id":[{"id":"10.13039\/100015230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.clon.2025.104003","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T16:52:13Z","timestamp":1765903933000},"page":"104003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical Trials in Molecular Radiotherapy: An Overview of the Landscape"],"prefix":"10.1016","volume":"51","author":[{"given":"N.","family":"Varmenot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Sj\u00f6green Gleisner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Taprogge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4743-2276","authenticated-orcid":false,"given":"G.D.","family":"Flux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2025.104003_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/jama.1946.02870190010003","article-title":"The treatment of hyperthyroidism with radioactive iodine","volume":"131","author":"Chapman","year":"1946","journal-title":"J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.clon.2025.104003_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1148\/35.1.51","article-title":"Nuclear Physics and Therapy: Preliminary Report on a New Method for the Treatment of Leukemia and Polycythemia","volume":"35","author":"Lawrence","year":"1940","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.clon.2025.104003_bib3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177\u2013PSMA-617 for Metastatic Castration-Resistant Prostate Cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.clon.2025.104003_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.clon.2025.104003_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clon.2025.104003_bib6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2967\/jnumed.123.266211","article-title":"Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial","volume":"65","author":"Garin","year":"2024","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.clon.2025.104003_bib7","first-page":"15N","article-title":"SNMMI Procedure Standard\/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version","volume":"63","author":"Avram","year":"2022","journal-title":"Journal of Nuclear Medicine"},{"issue":"8","key":"10.1016\/j.clon.2025.104003_bib8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"key":"10.1016\/j.clon.2025.104003_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1549676","article-title":"An overview of current phase 3 radiopharmaceutical therapy clinical trials","volume":"12","author":"Lepareur","year":"2025","journal-title":"Frontiers in Medicine"},{"issue":"8","key":"10.1016\/j.clon.2025.104003_bib10","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/d41573-025-00096-w","article-title":"The landscape for radioligand therapies in oncology","volume":"24","author":"To","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.clon.2025.104003_bib11","series-title":"Radioligand therapy market size & Share analysis - trends, drivers, competitive landscape, and forecasts","year":"2024"},{"key":"10.1016\/j.clon.2025.104003_bib12","series-title":"Natural Language processing with Python","author":"Bird","year":"2009"},{"issue":"17","key":"10.1016\/j.clon.2025.104003_bib13","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.3390\/molecules27175429","article-title":"Radionuclides for Targeted Therapy: Physical Properties","volume":"27","author":"Stokke","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.clon.2025.104003_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-02041-6","article-title":"Radiopharmaceuticals and their applications in medicine","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.clon.2025.104003_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1200\/CCI.20.00108","article-title":"OncoTree: A Cancer Classification System for Precision Oncology","volume":"5","author":"Kundra","year":"2021","journal-title":"JCO Clinical Cancer Informatics"},{"issue":"2","key":"10.1016\/j.clon.2025.104003_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.01019-20","article-title":"Evenness-Richness Scatter Plots: a Visual and Insightful Representation of Shannon Entropy Measurements for Ecological Community Analysis","volume":"6","author":"Gauthier","year":"2021","journal-title":"mSphere"},{"issue":"1","key":"10.1016\/j.clon.2025.104003_bib18","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1186\/s13063-022-06569-2","article-title":"Update on the clinical trial landscape: analysis of ClinicalTrials.gov registration data, 2000-2020","volume":"23","author":"Gresham","year":"2022","journal-title":"Trials"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655525002584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655525002584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:50:24Z","timestamp":1776149424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655525002584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":17,"alternative-id":["S0936655525002584"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2025.104003","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Trials in Molecular Radiotherapy: An Overview of the Landscape","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2025.104003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"104003"}}